16JUN

Ebola case fatality crosses 40% in DRC

2 min read

10:26UTC

Africa CDC put Bundibugyo case fatality at 44.1% on 27 July, up from about 39.7% a week earlier, and attributes the rise to later presentation and saturated treatment sites.

← Back to Bundibugyo's fork stays open Jump to analysis ↓

ScienceDeveloping

Key takeaway

Bundibugyo now kills 44.1% of confirmed cases, driven by late presentation rather than the virus.

Case fatality among confirmed Bundibugyo Ebola cases in DR Congo reached 44.1% on 27 July, up from roughly 39.7% a week earlier, Africa CDC reported ¹. The agency attributes the rise to patients arriving later and to treatment sites running full, not to any change in the pathogen. Its headline totals now stand at 3,380 confirmed cases and 1,489 deaths, against 2,344 and 930 seven days before .

Those totals need one caveat carried alongside them. Africa CDC's own chart note marks the 22 July step change as retrospective harmonisation with the Ituri and North Kivu case registers rather than a single-day surge ². Read off the chart gridlines, the back-filled portion runs somewhere near 350 to 400 cases, an estimate rather than a figure the agency states. A meaningful share of the apparent week is therefore old cases arriving late in the ledger, and the raw difference between the two totals overstates how fast the epidemic moved.

Readers reaching for the 2018-20 Kivu epidemic as a yardstick will reach wrong. Kivu killed about 66% of those it infected, but Kivu was Zaire ebolavirus, a different species from the Bundibugyo ebolavirus circulating now. Bundibugyo has two earlier outbreaks in the literature: Uganda in 2007, with 131 cases and 39 deaths, and Isiro in eastern DRC in 2012, with 38 cases and 13 deaths, close to 30% in the first and 34% in the second. Measured against Kivu, 44.1% looks merciful. Measured against its own species, it runs ten points above anything Bundibugyo has done before, and the drift from 39.7% in seven days is the part that should concern anyone reading the trend rather than the level. Isolation coverage was already near 44% when WHO put cases at 1,481 in early July ; untreated Ebola kills at rates no species comparison can soften.

Deep Analysis

In plain English

Case-fatality rate means the share of confirmed patients who die from the disease. It has climbed from about 40% to 44% in a week. Africa CDC says this is not because the virus has become more dangerous, but because sick people are reaching treatment later and the treatment sites they do reach are overloaded. Getting care quickly matters enormously with Ebola, so anything that delays it, whether that is distance, an overwhelmed hospital, or a shortage of isolation beds, translates directly into more deaths among the people who do get diagnosed.

Deep Analysis

Root Causes

Case-fatality in a filovirus outbreak rises when the interval between symptom onset and clinical care lengthens, because supportive treatment, fluids, electrolyte correction and organ support, is time-sensitive; a patient reaching a saturated treatment site late in the disease course has a materially worse prognosis than one admitted early, independent of the virus itself.

Treatment-site saturation compounds this: the same bed-capacity imbalance straining Nord-Kivu and the same testing bottleneck consuming isolation beds nationally both push presentation and admission later in the disease course, which is why Africa CDC links the case-fatality rise to logistics rather than pathogen change.

What could happen next?

Meaning
The rise from 39.7% to 44.1% case-fatality is attributed by Africa CDC to system strain, later presentation and saturated sites, not to a change in Bundibugyo ebolavirus's underlying lethality.
Consequence
A rising case-fatality rate driven by system strain will likely track the same bed-misallocation and testing-delay problems documented elsewhere in this update, rather than resolve independently.

Source Landscape

This story draws on neutral-leaning sources

Consensus view: Africa CDC attributes the rise from 39.7% on 20 July to 44.1% on 27 July to later patient presentation and saturated treatment sites rather than a change in the virus, a reading consistent with Bundibugyo ebolavirus's own clinical record: 30% case-fatality in the 2007 Uganda outbreak (131 cases, 39 deaths) and about 34% in the 2012 Isiro outbreak (38 cases, 13 deaths), both well below the roughly 66% case-fatality recorded in the 2018-20 Kivu epidemic, which was a different species, Zaire ebolavirus, not Bundibugyo.

Counter-view: Clinicians managing overflow wards in Nord-Kivu note the timing correlation is not yet proof of mechanism: case-fatality could also be rising because the confirmed-case denominator itself is shifting as testing catches up with a backlog of suspects, which would inflate the rate without any real change in how sick individual patients are.

Key tension: Whether the rising rate is a genuine signal that patients are dying more often because they reach care too late, or partly an artefact of how the confirmed-case count is being reconstructed alongside the reporting backlog.

Sources:Africa CDC

Mentions:Africa CDC →Bundibugyo ebolavirus →Zaire ebolavirus →DR Congo →Uganda →Ituri Province →South Kivu →World Health Organization →

First Reported In

Update #12 · Two-thirds of Ebola deaths never reach a ward

Africa CDC· 31 Jul 2026

Read original →

Causes and effects

Caused by

Most Ebola deaths never reach a ward

The same care-access gap driving community deaths lifts case-fatality as untreated cases skew fatal.

Occurred 27 Jul 2026

Read story →

This Event

Ebola case fatality crosses 40% in DRC

A threshold has been crossed, and the reason given is the state of the response rather than any change in the virus.

Different Perspectives

Chinese health authorities

China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.

US public health authorities

CIDRAP and Dr Andrew Racine, president of the American Academy of Pediatrics, call 2026's 2,318 confirmed measles cases by 24 July the worst year since 1991's 2,126. Zero deaths against three in 2025 and a 7% hospitalisation rate, down from 11%, show record case counts have not brought record severity.

CEPI

CEPI put an rVSV-platform vaccine candidate specific to Bundibugyo ebolavirus into trial-production on 31 July, developed by Hilleman Laboratories with MSD manufacturing and IAVI's reference virus, funded up to $8.5m. Eleven weeks into the third-largest Ebola outbreak on record, this is the first species-matched candidate; the licensed vaccine covers only Zaire ebolavirus.

Médecins Sans Frontières

MSF reports sexual-violence care in Ituri is almost non-existent, with 7 of 14 health centres closed or relocated by fighting, as Panzi Hospital logs 646 new survivors in six months, an 85% rise. Withdrawn US funding for post-exposure prophylaxis has left clinics across three provinces without PEP kits for months, a crisis running alongside Ebola, not caused by it.

DRC health workers at Elikya Ebola Treatment Centre

Staff at DRC's Elikya Ebola Treatment Centre walked out on 25 July over unpaid wages, the second such action after Rwampara, while unconfirmed suspects occupy up to 64% of the country's isolation beds awaiting lab results. Workers are absorbing a response that has grown faster than its payroll and its labs.

Uganda's Ministry of Health

Uganda's ministry says it discharged its last confirmed patient on 16 June, completed every contact's 21-day follow-up, and declared the country Ebola-free on 28 July, exactly 42 days later. It names Hon. Dr Chris Baryomunsi, Minister of Health, as overseeing a 20-case, 2-death outbreak it now considers closed.